Altimmune Inc Acceptance of IND for Covid-19 Therapeutic Testing - Call Transcript

Jun 01, 2020 / 12:30PM GMT
Operator

Greetings. Welcome to Altimmune, Inc. T-COVID Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Ms. Monique Kosse with LifeSci Advisors. Thank you. You may begin.

Monique Kosse - LifeSci Advisors, LLC - MD

Thank you, operator, and thank you, everyone, for participating in today's T-COVID Conference Call. Leading the call today will be Vipin Garg, Chief Executive Officer of Altimmune. Also participating on the call today is Scot Roberts, Chief Scientific Officer; Scott Harris, Chief Medical Officer; and Will Brown, Chief Financial Officer.

After their prepared remarks, we will open up the call for a question-and-answer session. A press release announcing the launch of the T-COVID program was issued this morning and can be found on the Investors page of the company's website.

Before we begin, I would like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot